New Published Data Demonstrate Long-Term Safety, Efficacy And…

New Published Data Demonstrate Long-Term Safety, Efficacy And Tolerability Of Watson’s RAFLO For Benign Prostatic Hyperplasia Main Category: Prostate / Prostate Cancer Also Included In: Urology / Nephrology Pharma Industry / Biotech Industry Watson Pharmaceuticals, Inc.

source : www.topix.com

Related News:

• What Messages Do Insulin (and Leptin) Send To The Brain
• Can parasites cause anemia and undernutrition in Northern Rwanda?
• Siemens Introduces Dedicated Ultrasound Solution For Obstetrics And Gynecology
• Amgen Highlights Data To Be Presented At American Society For Bone And Mineral Research (ASBMR) Meeting
• Home Births with Midwife Safe As Hospital for Babies, Fewer Infections and Less Bleeding for Moms
• Diet & Exercise & Transdermal Testosterone Reverses Metabolic Syndrome And Improves Glycaemic Control In Men With Newly Diagnosed Type 2 Diabetes
• Cosmeceuticals: Scrutinize ingredients, pick and choose best products
• ED Successfully Expands HIFU Business and Approval in New Territories
• Neurologist and internal medicine specialist join Community Memorial Hospital Medical staff
• In The Middle Of Brain Surgery, Patients Wake Up And Begin Talking

Details :
Submited at Friday, December 11th, 2009 at 1:00 am on Urology by ethan
Comment RSS 2.0 - leave a comment - trackback